NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,166 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $5,544,000 | +8.3% | 58,525 | -0.6% | 0.04% | 0.0% |
Q3 2019 | $5,119,000 | -2.4% | 58,869 | +2.6% | 0.04% | -5.0% |
Q2 2019 | $5,244,000 | +0.8% | 57,401 | +6.1% | 0.04% | -7.0% |
Q1 2019 | $5,201,000 | +19.9% | 54,088 | +7.1% | 0.04% | 0.0% |
Q4 2018 | $4,336,000 | +9.5% | 50,508 | +9.9% | 0.04% | +7.5% |
Q3 2018 | $3,961,000 | +39.7% | 45,971 | +22.5% | 0.04% | +2.6% |
Q2 2018 | $2,836,000 | -21.6% | 37,541 | -16.1% | 0.04% | -22.0% |
Q1 2018 | $3,618,000 | -27.4% | 44,720 | -24.6% | 0.05% | -25.4% |
Q4 2017 | $4,982,000 | +32.1% | 59,328 | +35.1% | 0.07% | +13.6% |
Q3 2017 | $3,771,000 | +14.1% | 43,905 | +11.0% | 0.06% | +1.7% |
Q2 2017 | $3,305,000 | +5.1% | 39,571 | -6.6% | 0.06% | -9.4% |
Q1 2017 | $3,146,000 | +7.3% | 42,368 | +5.3% | 0.06% | -3.0% |
Q4 2016 | $2,933,000 | +11.0% | 40,245 | +20.3% | 0.07% | +3.1% |
Q3 2016 | $2,642,000 | +6.9% | 33,457 | +11.5% | 0.06% | -1.5% |
Q2 2016 | $2,472,000 | – | 30,014 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |